STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skorpios Trust | 14,443,681 | $56,908,103 | 99.78% |
Lynx1 Capital Management LP | 1,710,154 | $6,738,007 | 4.46% |
COWEN AND COMPANY, LLC | 3,721,659 | $14,663,336 | 1.03% |
Redmile Group, LLC | 3,872,696 | $15,258,422 | 0.73% |
RTW INVESTMENTS, LP | 4,390,558 | $17,298,799 | 0.36% |
Birchview Capital, LP | 85,000 | $334,900 | 0.28% |
Cormorant Asset Management, LP | 1,087,807 | $4,285,960 | 0.25% |
Granahan Investment Management | 851,201 | $3,353,732 | 0.12% |
GSA CAPITAL PARTNERS LLP | 348,069 | $1,371 | 0.12% |
Simplify Asset Management Inc. | 102,985 | $405,761 | 0.05% |
Fort Point Capital Partners LLC | 75,429 | $297,190 | 0.04% |
Baker Brothers Advisors | 1,485,915 | $5,854,505 | 0.03% |
Corton Capital Inc. | 14,749 | $58,111 | 0.03% |
Ikarian Capital, LLC | 500 | $197,000 | 0.02% |
Virtus ETF Advisers LLC | 7,893 | $31,098 | 0.02% |
SHERBROOKE PARK ADVISERS LLC | 12,295 | $48,442 | 0.02% |
Trexquant Investment LP | 127,581 | $502,669 | 0.01% |
Ikarian Capital, LLC | 12,116 | $47,736 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 217,605 | $857,364 | 0.01% |
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 239,300 | $942,842 | 0.00% |
External links
This page lists STOKE THERAPEUTICS INC's shareholders in Q3 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.